University of Groningen
Lower risk of severe checkpoint inhibitor toxicity in more advanced disease
Verheijden, Rik J; May, Anne M; Blank, Christian U; van der Veldt, Astrid A M;
Boers-Sonderen, Marye J; Aarts, Maureen J B; van den Berkmortel, Franchette W P J; van den
Eertwegh, Alfonsus J M; de Groot, Jan Willem B; van der Hoeven, Jacobus J M
Published in: ESMO Open
DOI:
10.1136/esmoopen-2020-000945
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date: 2020
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Verheijden, R. J., May, A. M., Blank, C. U., van der Veldt, A. A. M., Boers-Sonderen, M. J., Aarts, M. J. B., van den Berkmortel, F. W. P. J., van den Eertwegh, A. J. M., de Groot, J. W. B., van der Hoeven, J. J. M., Hospers, G. A. P., Piersma, D., van Rijn, R. S., Ten Tije, A. J., Vreugdenhil, G., van Zeijl, M. C. T., Wouters, M. W. J. M., Haanen, J. B. A. G., Kapiteijn, E., & Suijkerbuijk, K. P. M. (2020). Lower risk of severe checkpoint inhibitor toxicity in more advanced disease. ESMO Open, 5(6), [000945].
https://doi.org/10.1136/esmoopen-2020-000945
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.
